• Jan. 13, 2016, 7:02 AM
    • Phibro Animal Health (NASDAQ:PAHC) acquires privately held MVP Laboratories for an undisclosed sum. The Omaha, Nebraska-based firm develops, manufactures and sells livestock vaccines, vaccine adjuvants and other products, including the MJPRRS autogenous swine vaccine, which Phibro exclusively distributes pursuant to its agreement with MJ Biologics.
    • The company will discuss the transaction during its investor conference call on February 10.
    Jan. 13, 2016, 7:02 AM